1. Artursson, P. and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.Biochem. Biophys. Res. Commun., 175, 880–885 (1991).
2. Cho, J. Y., Seo, H. B., Yu, K. S., Bae, K. S., Yi, S. Y., Jang, I. J., and Shin, S. G., Simple and sensitive determination of the new anti-tumor drug CKD-602 in human plasma by liquid chromatography.J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 784, 25–31 (2003).
3. Chu, X. Y., Kato, Y., Niinuma, K., Sudo, K. I., Hakusui, H., and Sugiyama, Y., Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.J. Pharmacol. Exp. Then, 281, 304–314 (1997a).
4. Chu, X. Y., Kato, Y., and Sugiyama, Y., Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats.Cancer Res., 57,1934–1938 (1997b).
5. Chu, X. Y., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., and Sugiyama, Y., Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters.Cancer Res., 58, 5137–5143 (1998).